American Oncology Network Welcomes Robert J. McDonald, MD, FACNM, as Radiology Medical Director and In-House Reading Radiologist

/in /by

Dr. McDonald’s Role Supports AON’s Growth in Radiotheranostics and Network-Wide RLT Capabilities.

Fort Myers, FL – Dec. 10, 2025 – American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, is pleased to announce the addition of Robert J. McDonald, MD, FACNM – a nationally recognized, board-certified nuclear medicine physician – as Radiology Medical Director and in-house reading radiologist. In this role, Dr. McDonald will support AON’s strategic expansion of radiotheranostic services throughout the network and strengthen AON’s commitment to delivering cutting-edge cancer care close to where patients live and work.

Dr. McDonald will serve as the primary reading radiologist for AON partner practices Florida Oncology & Hematology (FOH) in Naples and Fort Myers, and Central Georgia Cancer Care (CGCC) in Macon, providing expert interpretations for PET and CT imaging. He will also perform advanced radiotheranostic therapies at the Naples and Fort Myers location, while overseeing radiology services as Medical Director at each practice he supports.

As AON continues to expand its radiotheranostic footprint, Dr. McDonald will play an integral role in developing physicians, supporting future program growth, and bringing advanced RLT treatment options to more AON practice sites in 2026. The Nuclear Regulatory Commission (NRC) requires new Authorized Users of radioligand therapies to complete clinical preceptorships, and part of Dr. McDonald’s position includes conducting these preceptorships on-site when needed, helping ensure safe, timely expansion of radioligand expertise across the network.

In addition, Dr. McDonald will lead clinical refinement of AON’s RLT protocols and assist in the adoption and rollout of newly FDA-approved radiotheranostic therapies – further positioning AON at the forefront of innovation in community oncology.

“AON is at the leading edge of radiotheranostics in community oncology, and Dr. McDonald’s expertise will accelerate our ability to bring groundbreaking radioligand treatments to more patients across the country,” said Todd Schonherz, AON chief executive officer. “His leadership in clinical training, protocol development, and program expansion will be essential as we scale radiotheranostic services to additional AON practice sites in 2026 and beyond. We are proud to welcome him and look forward to what his presence will make possible for our physicians, our practices, and the patients we serve.”

“Bringing Dr. McDonald into these roles allows us to enhance the quality, continuity, and cost-effectiveness of radiological services across our practices,” said Guy Messer, AON vice president of radiation and radiology services. “His expertise strengthens our ability to deliver timely imaging and treatment while also advancing the expansion of radiotheranostics within AON – a core element of our commitment to improving access to next-generation cancer care in community settings.”

Dr. McDonald joins AON with more than 30 years of experience in diagnostic imaging and radioligand therapies. He previously served as the Medical Director of Imaging Services for Florida Cancer Specialists & Research Institute, specializing in PET/CT interpretation and therapeutic nuclear medicine.

His career includes leadership appointments at MD Anderson Cancer Center Orlando, extensive work with Radiology Regional Center in Southwest Florida, and leadership positions in major medical centers in Oregon and California. He has also held multiple leadership roles within the Society of Nuclear Medicine & Molecular Imaging and is a Fellow of the American College of Nuclear Medicine.

Dr. McDonald is a respected researcher, educator, and speaker who has contributed to numerous clinical studies and national presentations advancing nuclear medicine. He earned his medical degree from the Medical College of Virginia and completed his nuclear medicine residency at the University of California Irvine Medical Center.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Hawai’i Cancer Care and American Oncology Network Open New Kahului Clinic

/in /by

Hawai’i-based community oncology practice opens third location, expanding cancer care access for Maui patients.

KAHULUI, Hawai’i, Dec. 2, 2025 —Hawai’i Cancer Care, a partner practice of American Oncology Network (AON), today announced its expansion in Hawai’i with the opening of a new clinic in Kahului. The addition of this location – at 17 La’a Street, Unit B – provides Maui residents with greater access to high-quality, patient-centered cancer care close to home.

Board-certified medical oncologists Dr. Melvin P. Palalay and Dr. David J. Tamura and nurse practitioner Judy Ko, RN, MSN, APRN are now accepting patients at the Hawai’i Cancer Care – Kahului clinic, which will be open on Tuesdays and Wednesdays.

The new location includes private exam rooms designed for patient-physician consultations and an infusion room. New and existing patients can call (808) 727-8341 for more information or to schedule an appointment.

“We’re excited to welcome patients to our new Kahului clinic, where they’ll receive the same exceptional, compassionate care we provide at all Hawai’i Cancer Care locations,” said Dr. Palalay. “Our patient-first approach guides everything we do, and we’re committed to maintaining the highest standards of care for every person who walks through our doors.”

With the opening of the Kahului clinic, Hawai’i Cancer Care now operates three locations across the state. The practice is dedicated to providing comprehensive, research-based treatment for cancer and blood disorders through a holistic, team-oriented approach. Patients benefit from a full range of services – from diagnosis and treatment to survivorship and support – without the need to travel long distances for care.

“This new clinic allows us to make high-quality cancer care more accessible to patients on Maui,” said Dr. Tamura. “We look forward to serving this community and continuing our mission to deliver personalized care that meets each patient’s unique needs.”

For more information about American Oncology Network, visit AONcology.com. To learn more about Hawai’i Cancer Care, visit hawaiicancercare.com.

###

About Hawai’i Cancer Care

Hawai’i Cancer Care is dedicated to providing individualized, precision-based cancer treatment and supportive care to patients across O’ahu and Maui. The physicians of Hawai’i Cancer Care have been serving cancer patients in Hawai’i for more than 20 years. Hawai’i Cancer Care’s multidisciplinary team of highly trained physicians and medical professionals delivers comprehensive care using the latest treatment procedures, advanced technology, and access to a broad range of clinical trial programs.

Hawai’i Cancer Care recognizes that healing extends beyond medicine, offering emotional and educational support to help patients and their families navigate every step of the cancer journey—close to home and surrounded by their support network. Guided by a commitment to excellence, compassion, and innovation, Hawai’i Cancer Care strives to deliver the best possible experience and outcomes for every patient. Learn more at hawaiicancercare.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Evolent and American Oncology Network unveil innovative model seeking to improve cancer care while eliminating prior authorization burden

/in /by

Evolent and AON logos

WASHINGTON, NOVEMBER 6, 2025 – Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, and American Oncology Network (AON), one of the nation’s fastest-growing community oncology networks, today announced a new model enabling high-quality, more affordable, and connected cancer care — all without relying on prior authorization.

The national partnership seeks to improve clinical decision-making by introducing quality-focused interventions, driving clinical insights through an innovative data and analytics platform, and rewarding providers for high-quality care. As providers demonstrate adherence to quality, they will be “gold-carded” — no longer required to seek authorization from payers for most tests and treatments. Meanwhile, Evolent intends to use its care navigation program to complement AON’s existing capabilities to help patients manage daily life with cancer and stay better connected to their oncology team. AON and Evolent expect to roll out this model in select markets in the year ahead.

“Community oncology practices are a linchpin of our cancer care system, but they face immense pressures, from administrative burdens and financial stresses to care coordination needs,” said AON Chief Medical Officer Dr. Stephen “Fred” Divers. “With its provider-centric approach and uncompromising focus on doing what is best for patients, Evolent is an ideal partner. Evolent’s quality efforts go beyond common strategies that are largely tapped out — like shifting to biosimilars — to tackle some of the major drivers of quality and costs in cancer care.”

Key components of the program include:

  • Quality initiatives. Evolent and AON will help providers act on high-impact but underused opportunities to improve quality and affordability across the full continuum of care beyond traditional utilization management. The partnership seeks to drive sustained quality improvement through a systematic approach that combines provider education, scorecards, automated reminders delivered directly in the electronic medical record, and incentives.
  • AI-driven clinical insights. The model is powered in part by MiBA (Meaningful Insights Biotech Analytics), an innovative data and analytics platform co-developed in collaboration with AON, that supports providers with evidence-based insights and personalized cancer treatment plans. Harnessing real-time data in the electronic health record, the platform uses analytics and algorithms to uncover patterns, trends and correlations that can improve patient care and drive innovation.
  • Payment innovation. AON and Evolent are developing an aligned payment model seeking to reward oncology practices for delivering high-quality care. Moving beyond traditional fee-for-service models, the model aims to re-wire incentives to encourage providers to select the clinically optimal drug regimen for each patient.
  • Eliminating prior authorization. Providers who adhere to high-quality treatment pathways will no longer need prior authorization for most tests and treatments. This should accelerate the time to treatment and reduce the administrative burden for practices and patients.
  • Care navigation. AON patients will have access to Evolent’s comprehensive cancer care navigation program, which combines personalized navigation and a cancer care management platform, Careology, to help patients move through their journey with greater confidence and support. AON and Evolent believe this program will bolster AON’s existing care management capabilities and support the goal of end-to-end condition management.

“Patients, providers and health plans want the same thing out of the cancer journey — longer survival and a higher quality of life without unnecessary costs or hassles,” said Evolent President Dan McCarthy. “Yet, traditional models create friction between these groups as well as gaps, resulting in misaligned care, provider burnout and administrative waste. We’re thrilled to collaborate with American Oncology Network, as another leader in high-value cancer care, to create an ecosystem in which everyone wins when patients receive the best possible care.”

About Evolent

Evolent (NYSE: EVH) specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting evolent.com.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media inquiries

Evolent

Jamie Manfuso

media@evolent.com

American Oncology Network

Karen Riley Sawyer

Karen.Sawyer@AONcology.com

American Oncology Network Presents 15 Research Abstracts at ASCO Quality 2025

/in /by

FORT MYERS, Fla.—Oct. 10, 2025—American Oncology Network (AON), one of the fastest-growing community oncology networks in the nation, announced today that 15 research abstracts by AON physicians and leaders have been accepted for presentation at the American Society of Clinical Oncology (ASCO) Quality Care Symposium 2025. The event, themed Driving Solutions, Implementing Change, takes place Oct. 10-11 in Chicago.

AON leaders will present on a variety of topics including the Inflation Reduction Act’s influence on Enhancing Oncology Model (EOM) Part D expenditures and total cost of care (Abstract #2) and Inflation’s Toll on Oncology Physician Reimbursement (Abstract #21).

Physicians from American Oncology Network

A full list of AON physician and leader abstracts at the ASCO Quality Care Symposium include:

“It is an honor to share our research and latest findings with peers at ASCO’s Quality Care Symposium,” said Puneeth Indurlal, MD, AON’s senior vice president of strategic operations and co-author on all abstracts. “ASCO symposiums foster collaboration, innovation, and the advancement of clinical oncology. Our participation reflects our ongoing commitment to improving cancer care through evidence-based practices.”

“These studies – many in collaboration with our value-based care partner, Thyme Care – demonstrate the powerful combination of real-world clinical data and robust technology to harness it for the creation of value-based insights that will be used to improve community oncology today and tomorrow,” said Dr. Stephen “Fred” Divers, AON’s chief medical officer and co-author on all abstracts.

“Having so many AON physicians and leaders featured at ASCO’s Quality Care Symposium speaks volumes about the caliber of talent across our network,” said Todd Schonherz, AON’s chief executive officer and co-author on many abstracts. “We are proud that AON’s culture of innovation and learning is supporting ASCO in advancing the field of oncology.”

For more information about AON, visit AONcology.com.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Appears on Health Uncensored with Dr. Drew to Discuss New Partnership with CanCare, Inc.

/in /by

American Oncology Network + CanCare, Inc. = Holistic Community Cancer Support

October 9, 2025: AON Vice President of Clinical Innovation, Susan Sabo-Wagner and Dr. Kodityal from AON partner practice Woodlands Cancer Institute were recently featured alongside CanCare Inc. President and CEO, Darcie Champagne Wells on Health Uncensored with Dr. Drew to discuss the new partnership between AON and CanCare.

AON brings state-of-the-art cancer care to patients across the nation through community oncology practices in their own neighborhoods where they live and work. And CanCare ensures cancer patients receive the emotional support they need from cancer diagnosis through remission and beyond – pairing them with volunteers who have been through a similar diagnosis to provide the support and comfort they need to get through what is often the most difficult time of their lives.

AON + CanCare = Holistic physical and emotional cancer care support for patients in their own communities across the nation.

We couldn’t be prouder of this partnership and this segment! Watch it here:

American Oncology Network and The Center for Cancer and Blood Disorders Welcome Dr. Chitra Rajagopal

/in /by

Board-certified medical oncologist joins AON’s CCBD physician team

BETHESDA, MD, Oct. 7, 2025 –  American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its partner practice, The Center for Cancer and Blood Disorders (CCBD), today announced that medical oncologist Chitra Rajagopal, MD (“Dr. Raj”), has joined the physician care team. She will see patients in Germantown and Bethesda, Maryland, alongside the practice’s existing team of experienced providers.

Dr. Raj is Board-certified in medical oncology. She earned her medical degree from Stanley Medical College in Madras, India, where she graduated as the Best Outgoing Student. She completed her internship and residency in internal medicine at SUNY Downstate Medical Center in Brooklyn, followed by a fellowship in hematology and oncology and a subspecialty fellowship in bone marrow transplantation at Georgetown University Hospital’s Lombardi Cancer Center. Since 1997, she has provided comprehensive community-based cancer care, served as faculty at Georgetown University Hospital, and held leadership roles at Shady Grove Hospital. She has also been a member of the American Society of Clinical Oncology, the American Society of Hematology, the American College of Physicians, the American Medical Association, and the American Bone Marrow Transplant Registry.

“I am pleased to join The Center for Cancer and Blood Disorders,” said Dr. Raj. “This practice is well known for providing patient-centered, innovative care, and I am eager to contribute to its mission while caring for patients in our community.”

“We are thrilled to welcome Dr. Raj to our team,” said Ralph Boccia, MD, FACP, Medical Director and managing partner at CCBD. “Her dedication to evidence-based medicine and compassionate care will further enhance the high standard of service our patients have come to expect.”

“Dr. Raj brings a wealth of experience and commitment to excellence that aligns with AON’s mission,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Her expertise will be a tremendous asset to patients and providers across our Maryland network.”

CCBD provides community-based oncology services to patients in Bethesda, Germantown, and Baltimore, Maryland. The practice offers comprehensive cancer care, including diagnostics, cutting edge treatments, clinical trials that offer innovative opportunities, survivorship programs and patient support – all delivered close to home to reduce travel burdens for patients and their families. CCBD clinics feature private exam rooms and on-site infusion suites designed for patient comfort and privacy during treatment.

Dr. Raj is now seeing patients at CCBD’s Germantown and Bethesda locations. Germantown serves as her primary practice site, where she is currently available three days a week and will expand to four days a week beginning in January.

For more information about AON, visit AONcology.com. To learn more about The Center for Cancer and Blood Disorders, visit ccbdmd.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About The Center for Cancer and Blood Disorders
Specialists in the diagnosis and treatment of blood disorders and cancer, The Center for Cancer and Blood Disorders has been serving patients in the communities and surrounding areas of Bethesda, Germantown, and Baltimore, Maryland for more than 25 years. Their individualized approach to patient care includes chemotherapy, targeted therapy, immunotherapy and when appropriate, cutting-edge therapies on clinical trials. The practice regularly performs more than 300 clinical trials on new and developing diagnostic devices and techniques for cancer and diseases. Patients receive home delivery of oral cancer medications, in-house lab and pathology and on-site infusion therapy. The practice also offers comprehensive support with nutrition guidance and financial counseling. Learn more at ccbdmd.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Zangmeister Cancer Center Oncologist Dr. Taral Patel Presents Research at IASLC’s World Conference on Lung Cancer in Barcelona

/in /by

COLUMBUS, OHIO, Sept. 9, 2025 – American Oncology Network, one of the nation’s fastest-growing networks of community-based oncology practices, announced today that Board-certified medical oncologist Taral Patel, MD, of AON partner practice Zangmeister Cancer Center, authored and presented research at the IASLC 2025 World Conference on Lung Cancer, hosted by the International Association for the Study of Lung Cancer (#WCLC25) Sept. 6-9 in Barcelona, Spain.

Dr. Patel’s study, Assessment of molecular testing in stage IV non-small cell lung cancer patients across American Oncology Network, examined AON quality initiatives in collaboration with Integra Connect PrecisionQ to improve testing for stage IV patients. The abstract (Poster: P2.06.20) is available at cattendee.abstractsonline.com/meeting/21151/Session/180.

“Presenting our research at such a respected international conference was an incredible experience,” said Dr. Patel. “Having our work selected through a competitive process highlights its importance to the field. The opportunity to share findings with peers worldwide was both validating and inspiring, and it reinforced my commitment to advancing knowledge in lung cancer care.”

The IASLC World Conference on Lung Cancer is the largest global, multidisciplinary meeting focused solely on lung cancer and thoracic malignancies. Attendees include clinicians, researchers, allied health professionals, industry representatives, patients, survivors, caregivers and advocates.

“We are proud of Dr. Patel for presenting this important research on such a prominent stage,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “Our physicians’ contributions to the scientific community are central to who we are as a network. Research and knowledge-sharing not only strengthen patient care within our practices but also advance the broader understanding of cancer treatment worldwide.”

Dr. Patel is a Board-certified medical oncologist and hematologist at Zangmeister Cancer Center, an AON partner practice. He is a diplomate of the American Board of Internal Medicine in medical oncology. He earned his M.B.B.S. from Baroda Medical College at the Maharaja Sayajirao University in Gujarat, India, where he also completed his internship and residency in pathology. He later served as a research associate at the University of Illinois at Chicago, completed his residency in internal medicine at Cook County Hospital in Chicago, and his fellowship in hematology/oncology at the University of Cincinnati. The author of numerous peer-reviewed publications, Dr. Patel is a member of the Community Oncology Alliance, Columbus Medical Association, Ohio State Medical Association, Ohio Hematology Oncology Society and the American Society of Clinical Oncology.

For more information about AON, visit AONcology.com. To learn more about Zangmeister Cancer Center, visit zangcenter.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Zangmeister Cancer Center
Designed for easy access and patient comfort, the Zangmeister Cancer Center offers a holistic array of cancer care services, including diagnostic imaging and chemotherapy treatment, laboratory services, genetic consultation, a specialty pharmacy, social support services, and access to cancer clinical trials. Zangmeister’s highly skilled and compassionate physicians use the latest advancements in the diagnosis, treatment, and prevention of cancer and blood disorders. Learn more at zangcenter.com.

About the International Association for the Study of Lung Cancer
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study and eradication of lung and other thoracic malignancies, founded in 1974. Its mission is to improve patient care through research, education, and collaboration among its more than 8,000 multidisciplinary members, including medical specialists, scientists, patients, and their caregivers. Key activities include hosting the annual World Conference on Lung Cancer (WCLC), publishing the Journal of Thoracic Oncology (JTO), and developing important guidelines for classification and diagnosis.

About Integra Connect
Integra Connect is a value-based precision medicine company, leading the industry in real-world data, analytics and AI capabilities for specialty care organizations. While other companies may focus on one of these areas, Integra Connect’s combined approach means providers, payers, and life sciences companies can see beyond their own experience to understand the full realities of cancer care and improve care, embrace scientific advancements, manage costs and deliver innovations that benefit patients. Integra Connect has the industry’s largest foothold into oncology practices focused on value-based care, with more than 5,000 providers supported by its solutions. As part of the Oncology Care Model, Integra Connect generates more than $260M in value-based care revenue and more than $100M in shared savings for participating practices. This experience led the organization to co-develop and administer one of the largest commercial oncology alternative payment models in the U.S.

Media Contact
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@aoncology.com

American Oncology Network and Low Country Cancer Care Welcome Dr. Anton Juncaj

/in /by

Medical oncologist joins Low Country Cancer Care’s physician team

SAVANNAH, Ga., Sept. 9, 2025 –  American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its partner practice, Low Country Cancer Care, are pleased to welcome medical oncologist Anton Juncaj, DO, to the physician care team. He will work alongside Dr. George Negrea, Jennifer Yannucci, Haven Caldwell, and Stephen Tiley.

Dr. Juncaj earned his Doctor of Osteopathic Medicine from the Alabama College of Osteopathic Medicine and a Master of Arts in medical sciences from Boston University School of Medicine Graduate Medical Sciences. He completed his residency in internal medicine and fellowship training in oncology and hematology at Ascension Genesys Hospital in Grand Blanc, Michigan. He has experience treating a wide range of solid tumors, hematologic malignancies, and benign hematologic conditions.

“I am honored to join the physician team at Low Country Cancer Care,” said Dr. Juncaj. “The practice has built a strong reputation for innovative, patient-centered care, and its commitment to excellence closely aligns with my own approach to medicine. I look forward to caring for LCCC patients.”

The Low Country Cancer Care team now includes five medical oncologists providing high quality care with state-of-the-art technology and the latest advances in clinical research and therapies across five locations in Georgia and South Carolina. The practice is dedicated to delivering innovative cancer care rooted in evidence-based medicine and a holistic approach. Patients have access to a full spectrum of services for diagnosis, treatment, survivorship, and ongoing support close to home, eliminating the need for long-distance travel.

“We are thrilled to welcome Dr. Juncaj to Low Country Cancer Care,” shared medical oncologist Jennifer Yannucci, MD. “His knowledge and commitment to delivering compassionate, personalized care will enhance our team’s ability to offer patients the very best treatment options. We look forward to collaborating with him.”

“On behalf of AON, I am pleased to welcome Dr. Juncaj to Low Country Cancer Care and the network,” said Stephen “Fred” Divers, MD, AON’s chief medical officer. “His impressive training and patient-first philosophy make him an excellent fit for our community practices. I am confident that both patients and colleagues will benefit greatly from his skills and dedication.”

Dr. Juncaj will accept patients at the Statesboro clinic on Mondays and Wednesdays and the Savannah clinic on Tuesdays, Thursdays, and Fridays.

For more information about American Oncology Network, visit AONcology.com. For more information about Low Country Cancer Care, visit lcccsav.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Low Country Cancer Care
Low Country Cancer Care (LCCC) is a specialized practice devoted to the care of people with cancer and blood disorders as well as the prevention and eradication of these types of diseases. LCCC combines patient care, prevention, education, and research to benefit Georgia and South Carolina cancer patients. LCCC provides advanced treatment and world-class medicine in a warm, compassionate, and personalized environment. LCCC’s experienced and highly trained team is dedicated to providing high-quality diagnosis, treatment, and care with a human touch. Learn more at lcccsav.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

Genesis Cancer and Blood Institute and American Oncology Network Welcome Dr. Beau Hilton

/in /by

HOT SPRINGS, ARK., Sept. 2, 2025 –  Genesis Cancer and Blood Institute, a partner practice of American Oncology Network (AON), is pleased to welcome medical oncologist Beau Hilton, MD, to its physician care team. He joins an experienced group of physicians including Drs. Timothy Webb, Robert Muldoon, Stephen “Fred” Divers, Lynn Cleveland, Lingyi Chen, Sunil Kakadia, Kristen Sager, Brad Baltz, Jim Chen and Tyler Fugere.

Dr. Hilton earned his Doctor of Medicine from the Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He completed his internal medicine residency and hematology-oncology fellowship at Vanderbilt University Medical Center.

He is a member of the American Society of Hematology, the American Society of Clinical Oncology and the American College of Physicians. Dr. Hilton is passionate about providing personalized, patient-centered care in the community setting.

“I’m honored to join Genesis Cancer and Blood Institute,” said Dr. Hilton. “The practice has a long-standing reputation for exceptional patient care, and its mission aligns closely with my own values. I look forward to working alongside this dedicated team to provide leading-edge, compassionate treatment for our patients.”

With 11 medical oncologists and five advance practice providers across 11 locations in Arkansas,  Genesis Cancer and Blood Institute offers comprehensive services for cancer diagnosis, treatment, clinical trials, survivorship and patient support—all delivered close to home.

“We are delighted to welcome Dr. Hilton to our practice,” said Dr. Timothy Webb, medical oncologist at Genesis. “His expertise, compassion and dedication to individualized care make him a tremendous addition to our team. I’m confident our patients will benefit greatly from his knowledge and approach to treatment.”

“On behalf of AON, I’m thrilled to welcome Dr. Hilton to Genesis and to our national network,” said Stephen “Fred” Divers, MD, medical oncologist at Genesis and AON’s chief medical officer. “His skill, empathy and commitment to high-quality, community-based care are exactly what we value at AON. He will be an asset to both our team and the patients we serve every day.”

Dr. Hilton began seeing patients at both Genesis Hot Springs clinics on Sept. 1, 2025.

For more information about AON, visit AONcology.com. To learn more about Genesis Cancer and Blood Institute, visit genesiscancerblood.com.

About American Oncology Network
American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

About Genesis Cancer and Blood Institute
Specializing in the diagnosis and treatment of cancer and hematology, Genesis Cancer and Blood Institute is recognized for providing expert cancer care in Arkansas. The highly trained physicians, clinicians and staff are committed to ensuring the best possible outcomes for their patients. The medical oncology/hematology physicians at Genesis Cancer and Blood Institute include Dr. Brad Baltz, Dr. Jim Chen, Dr. R. Timothy Webb, Dr. Robert T. Muldoon, Dr. Stephen “Fred” Divers, Dr. A. Lynn Cleveland, Dr. Lingyi Chen, Dr. Sunil Kakadia, Dr. Kristen Sager, Dr. Tyler Fugere, and Dr. Beau Hilton. Learn more at genesiscancerblood.com.

Media Contact:
Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com

American Oncology Network Reports Strong Growth and Record Milestones in 2025

/in /by

Annual revenue surpasses $2 billion for the 12 months ended June 30, 2025, reflecting >40% growth over the prior 12-month period. Provider network grows to >300 across 20 states. New treatment innovations broaden access to cutting-edge cancer care

FORT MYERS, Fla., Aug. 12, 2025 – American Oncology Network (AON), one of the fastest-growing networks of community-based oncology practices in the United States, today announced the achievement of multiple key milestones. Fueled by new and expanding partnerships, groundbreaking treatment innovations, and a steadfast commitment to patient-centered care, AON continues to advance its mission of delivering world-class oncology care to more communities across the country.

With annual revenue surpassing $2 billion for the 12 months ended June 30, 2025, AON continues to demonstrate strong momentum. This revenue represents >40% growth over the 12 months ended June 30, 2024 and is driven by both organic expansion and the addition of numerous practices and providers in new markets. The network now includes more than 300 oncology and hematology providers across 20 states, offering expanded access to advanced treatments and diagnostics.

Looking ahead, AON is inviting new partners to join its growing national network, where they can preserve clinical autonomy and focus on patients while growing revenue with access to best-in-class support infrastructure including an in-house specialty pharmacy, revenue cycle management, prior authorization, innovative data and technology, and more. AON partner practices average a greater than 30% increase in sustainable income after joining. AON maintains a robust pipeline of practices interested in benefitting from AON’s unique value proposition.

“AON’s growth and momentum reflects the strength of our model and the commitment of our partner practices to transform how cancer care is delivered in communities across the country,” said Todd Schonherz, chief executive officer of AON. “We’re not just growing—we’re delivering measurable improvements in patient access, experience and outcomes.”

2025 YTD Growth and Innovation Highlights

A Vision for the Remainder of 2025

AON is positioned to amplify its national impact by advancing clinical innovation, strengthening partnerships and supporting the long-term sustainability of community oncology. Practices that join AON gain access to a robust suite of services and tools that help them grow while delivering exceptional care.

“We remain committed to ensuring that every patient receives personalized, high-quality care while reducing costs and improving outcomes,” said Dr. Stephen “Fred” Divers, chief medical officer of AON. “We’re proud to welcome new providers who share our vision and dedication to advancing care in the communities where patients live.”

For more information about AON, visit AONcology.com.

Financial Disclosure Advisory

This press release contains certain financial results for the twelve month period ended June 30, 2025. The financial results have not been audited or reviewed by the Company’s independent registered public accounting firm. Accordingly, the Company’s independent registered public accounting firm does not express an opinion with respect thereto, and you should not place undue reliance on such financial results. This press release also contains forward-looking statements, including but not limited to statements regarding anticipated growth, future treatment offerings, physician recruitment, and potential financial outcomes. These statements are based on current expectations and projections and are subject to risks and uncertainties that may cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. AON assumes no obligation to update or revise any such statements unless required by law.

About American Oncology Network

American Oncology Network (AON) is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. Founded in 2018, AON’s rapidly expanding network represents more than 300 providers practicing across 20 states. AON pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. AON equips its network physicians with the tools they need to thrive independently while providing comprehensive support, integrated revenue-diversifying ancillary services, and practice management expertise, enabling physicians to focus on what matters most – providing the highest standard of care for every patient. AON is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes. With a focus on innovation and collaboration, AON is shaping the future of community oncology. For more information, please visit AONcology.com or follow us on LinkedIn, Facebook, X (formerly Twitter) and YouTube.

Media Contact:

Karen Riley Sawyer
American Oncology Network
Karen.Sawyer@AONcology.com